Ambient bright light treatment improved proxy-rated sleep but not sleep measured by actigraphy in nursing home patients with dementia: a placebo-controlled randomised trial

Gunnhild J Hjetland, Eirin Kolberg, Ståle Pallesen, Eirunn Thun, Inger Hilde Nordhus, Bjørn Bjorvatn, Elisabeth Flo-Groeneboom, Gunnhild J Hjetland, Eirin Kolberg, Ståle Pallesen, Eirunn Thun, Inger Hilde Nordhus, Bjørn Bjorvatn, Elisabeth Flo-Groeneboom

Abstract

Background: Up to 70% of nursing home patients with dementia suffer from sleep problems. Light is the main zeitgeber to the circadian system and thus has a fundamental impact on sleep-wake behaviour. Low indoor light levels in nursing homes have been reported, and in combination with age-related reductions in light sensitivity, insufficient light exposure is likely to contribute to sleep problems in this population. Increasing daytime light exposure using bright light treatment (BLT) may represent a feasible non-pharmacological treatment for sleep problems in nursing home patients with dementia.

Methods: The present study reports on sleep outcomes, which are the primary outcomes of the DEM.LIGHT trial (Therapy Light Rooms for Nursing Home Patients with Dementia- Designing Diurnal Conditions for Improved Sleep, Mood and Behavioural Problems), a 24-week cluster-randomised placebo-controlled trial including 8 nursing home units and 69 resident patients. The intervention comprised ambient light of 1000 lx and 6000 K from 10:00 to 15:00, with gradually increasing and decreasing light levels prior to and following this interval, using ceiling mounted light-fixtures and light emitting diode technology. The placebo condition had continuous standard light levels (150-300 lx, ~ 3000 K). Sleep was assessed at baseline and follow-up at week 8, 16, and 24, using the proxy-rated Sleep Disorder Inventory (SDI) and actigraphy (Actiwatch II, Philips Respironics). Mixed linear models were used to evaluate intervention effects, adjusting for relevant covariates such as age, gender, number of drugs, severity of dementia, eye disease, and estimated light exposure.

Results: Sleep as measured by the SDI was significantly improved in the intervention group compared to the control group from baseline to week 16 (B = - 0.06, 95% CI -0.11 - -0.01, p < .05) and from baseline to week 24 (B = - 0.05, 95% CI -0.10 - -0.01, p < .05). There was no effect according to the SDI at week 8 and no significant effects in terms of actigraphically measured sleep.

Conclusions: Proxy-rated sleep improved among nursing home patients with dementia following 16 and 24 weeks of BLT. These improvements were not corroborated by actigraphy recordings.

Trial registration: ClinicalTrials.gov Identifier: NCT03357328 . Registered 29 November 2017 - Retrospectively registered.

Keywords: Actigraphy; Dementia; Nursing home; Sleep; Sleep disorder inventory.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
An illustration of the intervention light sequence. The light changed gradually across 30 min between each condition. Each nursing home could choose if they wanted to turn the lights off or to maintain 100 lx and 2500 K throughout the night (21:00–07:00). The patients generally did not spend time in the common room during the night, and whether or not the light was on in the common room depended on the needs of the staff during the night
Fig. 2
Fig. 2
Showing the flow of participants from eligibility assessment to study completion. Note: Main cause for moving was a deterioration of somatic health requiring the patient to live in a somatic ward
Fig. 3
Fig. 3
Overview of missing data and reason for missing at each data collection time point, not including those lost to follow-up

References

    1. American Psychiatric Association. Neurocognitive disorders. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington DC; 2013.
    1. Wimo A, Guerchet M, Ali G-C, Wu Y-T, Prina AM, Winblad B, et al. The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement. 2017;13(1):1–7. doi: 10.1016/j.jalz.2016.07.150.
    1. World Health Organization. Dementia [Internet]. 2019. Available from:
    1. Webster L, Costafreda Gonzalez S, Stringer A, Lineham A, Budgett J, Kyle S, et al. Measuring the prevalence of sleep disturbances in people with dementia living in care homes: a systematic review and meta-analysis. Sleep. 2019;43:zsz251. doi: 10.1093/sleep/zsz251.
    1. Wulff K, Gatti S, Wettstein JG, Foster RG. Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci. 2010;11(8):589–599. doi: 10.1038/nrn2868.
    1. Ornstein K, Gaugler JE. The problem with “problem behaviors”: a systematic review of the association between individual patient behavioral and psychological symptoms and caregiver depression and burden within the dementia patient–caregiver dyad. Int Psychogeriatr. 2012;24(10):1536–1552. doi: 10.1017/S1041610212000737.
    1. Brassington GS, King AC, Bliwise DL. Sleep problems as a risk factor for falls in a sample of community-dwelling adults aged 64–99 years. J Am Geriatr Soc. 2000;48(10):1234–1240. doi: 10.1111/j.1532-5415.2000.tb02596.x.
    1. Stone KL, Ancoli-Israel S, Blackwell T, Ensrud KE, Cauley JA, Redline S, et al. Actigraphy-measured sleep characteristics and risk of falls in older women. Arch Intern Med Am Med Assoc. 2008;168(16):1768–75. doi: 10.1001/archinte.168.16.1768.
    1. Anderson KN, Catt M, Collerton J, Davies K, von Zglinicki T, Kirkwood TB, et al. Assessment of sleep and circadian rhythm disorders in the very old: the Newcastle 85+ cohort study. Age Ageing. 2014;43(1):57–63. doi: 10.1093/ageing/aft153.
    1. Arbus C, Gardette V, Cantet CE, Andrieu S, Nourhashémi F, Schmitt L, et al. Incidence and predictive factors of depressive symptoms in Alzheimer’s disease: the study. J Nutr Health Aging. 2011;15(8):609–617. doi: 10.1007/s12603-011-0061-1.
    1. Guarnieri B, Adorni F, Musicco M, Appollonio I, Bonanni E, Caffarra P, et al. Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients. Dement Geriatr Cogn Disord. 2012;33(1):50–8. doi: 10.1159/000335363.
    1. Tractenberg RE, Singer CM, Cummings JL, Thal LJ. The sleep disorders inventory: an instrument for studies of sleep disturbance in persons with Alzheimer’s disease. J Sleep Res. 2003;12(4):331–337. doi: 10.1046/j.0962-1105.2003.00374.x.
    1. Yaffe K, Falvey CM, Hoang T. Connections between sleep and cognition in older adults. Lancet Neurol. 2014;13(10):1017–1028. doi: 10.1016/S1474-4422(14)70172-3.
    1. Deschenes CL, McCurry SM. Current treatments for sleep disturbances in individuals with dementia. Curr Psychiatry Rep. 2009;11(1):20–26. doi: 10.1007/s11920-009-0004-2.
    1. Sterke CS, van Beeck EF, van der Velde N, Ziere G, Petrovic M, Looman CW, et al. New insights: dose-response relationship between psychotropic drugs and falls: a study in nursing home residents with dementia. J Clin Pharmacol. 2012;52(6):947–955. doi: 10.1177/0091270011405665.
    1. McCleery J, Cohen DA, Sharpley AL. Pharmacotherapies for sleep disturbances in Alzheimer’s disease. BJPsych Adv. 2015;21(4):218–8. doi: 10.1192/apt.21.4.218.
    1. Pat-Horenczyk R, Klauber MR, Shochat T, Ancoli-Israel S. Hourly profiles of sleep and wakefulness in severely versus mild-moderately demented nursing home patients. Aging Clin Exp Res. 1998;10(4):308–315. doi: 10.1007/BF03339793.
    1. Wennberg AM, Wu MN, Rosenberg PB, Spira AP. Sleep disturbance, cognitive decline, and dementia: a review. Semin Neurol. 2017;37:395–406. doi: 10.1055/s-0037-1604351.
    1. Neikrug AB, Ancoli-Israel S. Sleep disturbances in nursing homes. J Nutr Health Aging. 2010;14(3):207–211. doi: 10.1007/s12603-010-0051-8.
    1. Peter-Derex L, Yammine P, Bastuji H, Croisile B. Sleep and Alzheimer’s disease. Sleep Med Rev. 2015;19:29–38. doi: 10.1016/j.smrv.2014.03.007.
    1. Figueiro MG, Hamner R, Higgins P, Hornick T, Rea MS. Field measurements of light exposures and circadian disruption in two populations of older adults. J Alzheimers Dis. 2012;31(4):711–715. doi: 10.3233/JAD-2012-120484.
    1. Shochat T, Martin J, Marler M, Ancoli-Israel S. Illumination levels in nursing home patients: effects on sleep and activity rhythms. J Sleep Res. 2000;9(4):373–379. doi: 10.1046/j.1365-2869.2000.00221.x.
    1. Czeisler CA, Buxton OM. Human circadian timing system and sleep-wake regulation. In: Kryger M, Roth T, Dement WC, editors. Principles and Practice of Sleep Medicine. 5. United States: Elsevier Inc; 2010. pp. 402–419.e5.
    1. Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science. 2002;295(5557):1070–1073. doi: 10.1126/science.1067262.
    1. Dacey DM, Liao H-W, Peterson BB, Robinson FR, Smith VC, Pokorny J, et al. Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN. Nature. 2005;433(7027):749–54. 10.1038/nature03387.
    1. Cajochen C, Munch M, Kobialka S, Krauchi K, Steiner R, Oelhafen P, et al. High sensitivity of human melatonin, alertness, thermoregulation, and heart rate to short wavelength light. J Clin Endocrinol Metab. 2005;90(3):1311–1316. doi: 10.1210/jc.2004-0957.
    1. Brainard GC, Hanifin JP, Warfield B, Stone MK, James ME, Ayers M, et al. Short-wavelength enrichment of polychromatic light enhances human melatonin suppression potency. J Pineal Res. 2015;58(3):352–61. 10.1111/jpi.12221.
    1. Peyvandi S, Hernández-Andrés J, Olmo FJ, Nieves JL, Romero J. Colorimetric analysis of outdoor illumination across varieties of atmospheric conditions. JOSA A. 2016;33(6):1049–1059. doi: 10.1364/JOSAA.33.001049.
    1. Duffy JF, Zitting K-M, Chinoy ED. Aging and circadian rhythms. Sleep Med Clin. 2015;10(4):423–434. doi: 10.1016/j.jsmc.2015.08.002.
    1. Turner PL, Mainster MA. Circadian photoreception: ageing and the eye’s important role in systemic health. Br J Ophthalmol. 2008;92(11):1439–1444. doi: 10.1136/bjo.2008.141747.
    1. Najjar RP, Chiquet C, Teikari P, Cornut P-L, Claustrat B, Denis P, et al. Aging of non-visual spectral sensitivity to light in humans: compensatory mechanisms? PLoS One. 2014;9(1):e85837. 10.1371/journal.pone.0085837.
    1. Kessel L, Siganos G, Jørgensen T, Larsen M. Sleep disturbances are related to decreased transmission of blue light to the retina caused by lens yellowing. Sleep. 2011;34(9):1215–1219. doi: 10.5665/SLEEP.1242.
    1. La Morgia C, Ross-Cisneros FN, Sadun AA, Carelli V. Retinal ganglion cells and circadian rhythms in Alzheimer’s disease, Parkinson’s disease, and beyond. Front Neurol. 2017;8:162. doi: 10.3389/fneur.2017.00162.
    1. Ancoli-Israel S, Klauber MR, Jones DW, Kripke DF, Martin J, Mason W, et al. Variations in circadian rhythms of activity, sleep, and light exposure related to dementia in nursing-home patients. Sleep. 1997;20:18–23. doi: 10.1093/sleep/20.1.24.
    1. De Lepeleire J, Bouwen A, De Coninck L, Buntinx F. Insufficient lighting in nursing homes. J Am Med Dir Assoc. 2007;8(5):314–317. doi: 10.1016/j.jamda.2007.01.003.
    1. Konis K. Field evaluation of the circadian stimulus potential of daylit and non-daylit spaces in dementia care facilities. Build Environ. 2018;135:112–123. doi: 10.1016/j.buildenv.2018.03.007.
    1. Sinoo MM, van Hoof J, Kort HS. Light conditions for older adults in the nursing home: assessment of environmental illuminances and colour temperature. Build Environ. 2011;46(10):1917–1927. doi: 10.1016/j.buildenv.2011.03.013.
    1. Kolberg E, Pallesen S, Hjetland GJ, Nordhus IH, Thun E, Flo-Groeneboom E. Insufficient melanopic equivalent daylight illuminance in nursing home dementia units across seasons and gaze directions. Light Res Technol. 2021. 1477153521994539.
    1. Li DHW, Lau CCS, Lam JC. Predicting daylight illuminance on inclined surfaces using sky luminance data. Energy. 2005;30(9):1649–1665. doi: 10.1016/j.energy.2004.04.038.
    1. Norton TT, Siegwart JT., Jr Light levels, refractive development, and myopia–a speculative review. Exp Eye Res. 2013;114:48–57. doi: 10.1016/j.exer.2013.05.004.
    1. Ancoli-Israel S, Gehrman P, Martin JL, Shochat T, Marler M, Corey-Bloom J, et al. Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer’s disease patients. Behav Sleep Med. 2003;1(1):22–36. 10.1207/S15402010BSM0101_4.
    1. Fetveit A, Skjerve A, Bjorvatn B. Bright light treatment improves sleep in institutionalised elderly—an open trial. Int J Geriatri Psych. 2003;18(6):520–526. doi: 10.1002/gps.852.
    1. Lyketsos CG, Veiel LL, Baker A, Steele C. A randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long-term care. Int J Geriatr Psychiatry. 1999;14(7):520–525. doi: 10.1002/(SICI)1099-1166(199907)14:7<520::AID-GPS983>;2-M.
    1. Mishima K, Okawa M, Hishikawa Y, Hozumi S, Hori H, Takahashi K. Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatr Scand. 1994;89(1):1–7. doi: 10.1111/j.1600-0447.1994.tb01477.x.
    1. Mishima K, Hishikawa Y, Okawa M. Randomized, dim light controlled, crossover test of morning bright light therapy for rest-activity rhythm disorders in patients with vascular dementia and dementia of Alzheimer’s type. Chronobiol Int. 1998;15(6):647–654. doi: 10.3109/07420529808993200.
    1. Satlin A, Volicer L, Ross V, Herz L, Campbell S. Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer’s disease. Am J Psychiatry. 1992;149:1028–1032. doi: 10.1176/ajp.149.8.1028.
    1. Yamadera H, Ito T, Suzuki H, Asayama K, Ito R, Endo S. Effects of bright light on cognitive and sleep-wake (circadian) rhythm disturbances in Alzheimer-type dementia. Psychiatry Clin Neurosci. 2000;54(3):352–353. doi: 10.1046/j.1440-1819.2000.00711.x.
    1. Ancoli-Israel S, Martin JL, Kripke DF, Marler M, Klauber MR. Effect of light treatment on sleep and circadian rhythms in demented nursing home patients. J Am Geriatr Soc. 2002;50(2):282–289. doi: 10.1046/j.1532-5415.2002.50060.x.
    1. Burns A, Allen H, Tomenson B, Duignan D, Byrne J. Bright light therapy for agitation in dementia: a randomized controlled trial. Int Psychogeriatr. 2009;21(4):711–721. doi: 10.1017/S1041610209008886.
    1. Skjerve A, Bjorvatn B, Holsten F. Light therapy for behavioural and psychological symptoms of dementia. Int J Geriatri Psych. 2004;19(6):516–522. doi: 10.1002/gps.1087.
    1. Hjetland GJ, Pallesen S, Thun E, Kolberg E, Nordhus IH, Flo E. Light interventions and sleep, circadian, behavioral, and psychological disturbances in dementia: a systematic review of methods and outcomes. Sleep Med Rev. 2020:101310.
    1. Chiu H-L, Chan P-T, Chu H, Hsiao S-TS, Liu D, Lin C-H, et al. Effectiveness of light therapy in cognitively impaired persons: a metaanalysis of randomized controlled trials. J Am Geriatr Soc. 2017;65(10):2227–34. 10.1111/jgs.14990.
    1. van Maanen A, Meijer AM, van der Heijden KB, Oort FJ. The effects of light therapy on sleep problems: a systematic review and meta-analysis. Sleep Med Rev. 2016;29:52–62. doi: 10.1016/j.smrv.2015.08.009.
    1. Schulz KF, Altman DG, Moher D. the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8:18. doi: 10.1186/1741-7015-8-18.
    1. Lucas RJ, Peirson SN, Berson DM, Brown TM, Cooper HM, Czeisler CA, et al. Measuring and using light in the melanopsin age. Trends Neurosci. 2014;37(1):1–9. 10.1016/j.tins.2013.10.004.
    1. Hjetland GJ, Nordhus IH, Pallesen S, Cummings J, Tractenberg RE, Thun E, et al. An Actigraphy-based validation study of the sleep disorder inventory in the nursing home. Front Psychiatr. 2020;11:173. 10.3389/fpsyt.2020.00173.
    1. Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. The role of actigraphy in the study of sleep and circadian rhythms. Sleep. 2003;26(3):342–392. doi: 10.1093/sleep/26.3.342.
    1. Blytt KM, Bjorvatn B, Husebo B, Flo E. Clinically significant discrepancies between sleep problems assessed by standard clinical tools and actigraphy. BMC Geriatr. 2017;17(1):253. doi: 10.1186/s12877-017-0653-7.
    1. Fetveit A, Bjorvatn B. Sleep disturbances among nursing home residents. Int J Geriatri Psych. 2002;17(7):604–609. doi: 10.1002/gps.639.
    1. Martin JL, Webber AP, Alam T, Harker JO, Josephson KR, Alessi CA. Daytime sleeping, sleep disturbance, and circadian rhythms in the nursing home. Am J Geriatr Psychiatry. 2006;14(2):121–129. doi: 10.1097/01.JGP.0000192483.35555.a3.
    1. Camargos EF, Louzada FM, Nóbrega OT. Wrist actigraphy for measuring sleep in intervention studies with Alzheimer’s disease patients: application, usefulness, and challenges. Sleep Med Rev. 2013;17(6):475–488. doi: 10.1016/j.smrv.2013.01.006.
    1. Brown DT, Westbury JL, Schüz B. Sleep and agitation in nursing home residents with and without dementia. Int Psychogeriatr. 2015;27(12):1945–1955. doi: 10.1017/S1041610215001568.
    1. Bonanni E, Maestri M, Tognoni G, Fabbrini M, Nucciarone B, Manca ML, et al. Daytime sleepiness in mild and moderate Alzheimer’s disease and its relationship with cognitive impairment. J Sleep Res. 2005;14(3):311–317. doi: 10.1111/j.1365-2869.2005.00462.x.
    1. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6.
    1. Sclan SG, Reisberg B. Functional assessment staging (FAST) in Alzheimer’s disease: reliability, validity, and ordinality. Int Psychogeriatr. 1992;4(3):55–69. doi: 10.1017/S1041610292001157.
    1. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi: 10.1016/0021-9681(87)90171-8.
    1. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3 Part 1):179–186. doi: 10.1093/geront/9.3_Part_1.179.
    1. Selbaek G, Kirkevold Ø, Sommer OH, Engedal K. The reliability and validity of the Norwegian version of the neuropsychiatric inventory, nursing home version (NPI-NH) Int Psychogeriatr. 2008;20(2):375–382. doi: 10.1017/S1041610207005601.
    1. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308–8. 10.1212/WNL.44.12.2308.
    1. Faul F, Erdfelder E, Buchner A, Lang A-G. Statistical power analyses using G* power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149–1160. doi: 10.3758/BRM.41.4.1149.
    1. Donner A. Some aspects of the design and analysis of cluster randomization trials. J R Stat Soc C-Appl Wiley Online Library. 1998;47:95–113. doi: 10.1111/1467-9876.00100.
    1. Franke RH, Kaul JD. The Hawthorne experiments: first statistical interpretation. Am Sociol Rev. 1978;43(5):623–643. doi: 10.2307/2094540.
    1. McCarney R, Warner J, Iliffe S, Van Haselen R, Griffin M, Fisher P. The Hawthorne effect: a randomised, controlled trial. BMC Med Res Methodol. 2007;7(1):30. doi: 10.1186/1471-2288-7-30.
    1. Akobeng AK. Assessing the validity of clinical trials. J Pediatr Gastr Nutr. 2008;47(3):277–282. doi: 10.1097/MPG.0b013e31816c749f.
    1. R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for statistical Computing; 2014. Available from:
    1. Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. arXiv preprint arXiv:14065823. 2014;
    1. Adamis D. Statistical methods for analysing longitudinal data in delirium studies. Int Rev Psychiatry. 2009;21(1):74–85. doi: 10.1080/09540260802675346.
    1. Brown H, Prescott R. Applied mixed models in medicine. John Wiley & Sons; 2014.
    1. Sloane PD, Figueiro M, Garg S, Cohen LW, Reed D, Williams CS, et al. Effect of home-based light treatment on persons with dementia and their caregivers. Light Res Technol. 2015;47(2):161–76. 10.1177/1477153513517255.
    1. Figueiro MG, Hunter CM, Higgins P, Hornick T, Jones GE, Plitnick B, et al. Tailored lighting intervention for persons with dementia and caregivers living at home. Sleep Health. 2015;1(4):322–330. doi: 10.1016/j.sleh.2015.09.003.
    1. McCurry SM, Pike KC, Vitiello MV, Logsdon RG, Larson EB, Teri L. Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer’s disease: results of a randomized, controlled trial. J Am Geriatr Soc. 2011;59(8):1393–1402. doi: 10.1111/j.1532-5415.2011.03519.x.
    1. Van De Water AT, Holmes A, Hurley DA. Objective measurements of sleep for non-laboratory settings as alternatives to polysomnography–a systematic review. J Sleep Res. 2011;20(1pt2):183–200. doi: 10.1111/j.1365-2869.2009.00814.x.
    1. Sivertsen B, Omvik S, Havik OE, Pallesen S, Bjorvatn B, Nielsen GH, et al. A comparison of actigraphy and polysomnography in older adults treated for chronic primary insomnia. Sleep. 2006;29(10):1353–8. 10.1093/sleep/29.10.1353.
    1. Toften S, Pallesen S, Hrozanova M, Moen F, Grønli J. Validation of sleep stage classification using non-contact radar technology and machine learning (Somnofy®) Sleep Med Elsevier. 2020;75:54–61. doi: 10.1016/j.sleep.2020.02.022.
    1. Linjakumpu TA, Hartikainen SA, Klaukka TJ, Koponen HJ, Hakko HH, Viilo KM, et al. Sedative drug use in the home-dwelling elderly. Ann Pharmacother. 2004;38(12):2017–22. 10.1345/aph.1E067.
    1. Husebo BS, Strand LI, Moe-Nilssen R, Husebo SB, Snow AL, Ljunggren AE. Mobilization-observation-behavior-intensity-dementia pain scale (MOBID): development and validation of a nurse-administered pain assessment tool for use in dementia. J Pain Symptom Manag. 2007;34(1):67–80. doi: 10.1016/j.jpainsymman.2006.10.016.
    1. Sloane PD, Williams CS, Mitchell CM, Preisser JS, Wood W, Barrick AL, et al. High-intensity environmental light in dementia: effect on sleep and activity. J Am Geriatr Soc. 2007;55(10):1524–33. 10.1111/j.1532-5415.2007.01358.x.
    1. Gentili A, Weiner DK, Kuchibhatla M, Edinger JD. Factors that disturb sleep in nursing home residents. Aging Clin Exp Res. 1997;9(3):207–213. doi: 10.1007/BF03340151.
    1. Grelotti DJ, Kaptchuk TJ. Placebo by proxy. BMJ. 2011;343(aug11 2):d4345. doi: 10.1136/bmj.d4345.
    1. Bierman A, Klein TR, Rea MS. The Daysimeter: a device for measuring optical radiation as a stimulus for the human circadian system. Meas Sci Technol. 2005;16(11):2292–2299. doi: 10.1088/0957-0233/16/11/023.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe